Experience

Sanity Closes $85 Million Series C

May 8, 2025

Cooley advised Sanity, a content management system that helps build dynamic, content-rich experiences and streamline content workflows, on its $85 Million Series C.

Read more

Related contacts

Kevin Rooney
Partner, San Francisco
John Paul Oleksiuk
Partner, New York
Karen Tsai
Special Counsel, Washington, DC
Ida Mahmoudi
Associate, San Francisco
Narmada Murugan
Associate, Palo Alto
Alice Wu
Associate, Palo Alto
Jake Ironfield
Transactional Quantitative Analyst, New York
Charles Haley
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Lowell Mead
Partner, Palo Alto
John Sellers
Senior Counsel, Palo Alto
Dillon Martinson
Special Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Amanda Pacheco
Associate, Palo Alto
Allison Pang
Associate, Palo Alto
Shelby Saunders
Associate, New York
Rubin Waranch
Associate, Colorado
David H. Zhou
Associate, Palo Alto
Melanie Yuvienco
Paralegal Specialist, Palo Alto

Related Practices & Industries

Datadog Acquires Eppo

May 7, 2025

Cooley advised Datadog (Nasdaq: DDOG), a monitoring and security platform for cloud applications, on its acquisition of Eppo, a feature flagging and experimentation platform that will tightly integrate with Datadog’s existing product analytics suite.

Read more

Related contacts

Izzy Lubarsky
Partner, New York
Grigor Lynch
Associate, Colorado
Brittany Sanok
Associate, New York
Eileen Marshall
Partner, Washington, DC
Austin Holt
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Len Jacoby
Partner, New York
Ross Eberly
Partner, Santa Monica
Kristen Mathews
Partner, New York
Megan Browdie
Partner, Washington, DC
Brad Goldberg
Partner, New York
Stella Sarma
Partner, Brussels
Leo Spicer-Phelps
Partner, London
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Stacey A. Bradford
Special Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Ryan Bowers
Associate, Washington, DC
David Dalton
Associate, Santa Monica
Cristina DeBiase
Associate, Boston
Megan Drill
Associate, San Diego
Joshua Elefant
Associate, Palo Alto
Nathaniel Hearn Jr.
Associate, Chicago
Allison Kutner
Associate, New York
Edward McLaughlin
Associate, New York
Anisha Mohin
Associate, New York
Juan Nascimbene
Associate, London
Liz Paisner
Associate, New York
Shelby Saunders
Associate, New York
Patricia Myers
Paralegal Specialist, Colorado
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Breton Technology Announces HK$234 Million IPO

May 7, 2025

Cooley advised Breton Technology, an electric-powered engineering machinery provider based in China, on its HK$234 million global initial public offering (IPO).

Read more

Related contacts

Ethan Jin
Partner, Beijing
Will Cai
Partner, Hong Kong
Caroline Hobson
Partner, London
Lisa Yuan
Special Counsel, Beijing
Karen Tsai
Special Counsel, Washington, DC
Marcus Chen
Associate, Beijing
Dichun Duan
Associate, Beijing
Juan Nascimbene
Associate, London
Chad Li
International Legal Project Manager, Beijing
Zoe Wang
International Legal Project Manager, Shanghai
Jin Wang
Senior Legal Assistant, Beijing

Related Practices & Industries

Reducto Announces $24.5 Million Series A

April 25, 2025

Cooley represented Reducto, a platform for unlocking unstructured data for artificial intelligence pipelines, on its $24.5 million Series A financing.

Read more

Related contacts

Tara Capsuto
Partner, San Francisco
Jeremy Ungerman-Sears
Associate, San Francisco
Julianne Orr
Associate, San Francisco
John Sellers
Senior Counsel, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
Karen Tsai
Special Counsel, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Chu Lee
Paralegal Specialist, San Francisco
Michael Suyat
Senior Paralegal, San Francisco
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

DualityBio Announces HK$1.64 Billion IPO

April 24, 2025

Cooley advised the underwriters of Duality Biologics (DualityBio), a clinical-stage biotech company focused on the discovery and development of next-generation antibody-drug conjugate therapeutics for patients with cancer and autoimmune diseases, in connection with its HK$1.64 billion global initial public offering (IPO).

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Xander Lee
Partner, Santa Monica
Vince Sampson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Monica Xu
Special Counsel, Shanghai
Hilda Li
Associate, Hong Kong
Zixiang Liu
Associate, Shanghai
Patrick Sharma
Associate, Santa Monica
Yiying Wang
Associate, Shanghai
Yunxiang Xu
Associate, Shanghai
Kaiting Yang
Associate, Hong Kong
Tonny Yu
Associate, Hong Kong
Tonny Yu
Associate, Hong Kong
Letian Wei
Legal Consultant, Shanghai
Cindy Pan
International Legal Project Manager, Hong Kong
Zoe Wang
International Legal Project Manager, Shanghai
Philip Kwan
Senior Legal Assistant, Hong Kong
Jin Wang
Senior Legal Assistant, Beijing

Related Practices & Industries

View more

Admissions and credentials

District of Columbia

New York